technology


ManifestSeven’s Cannabis Superhighway Aims to Provide a Consistent Experience

August 7th, 2019 - Ryan Allway

    The cannabis industry is projected to reach $5.1 billion by the end of the year, according to BDS Analytics and Arcview Market Research, making it the largest single market in the world. Despite its massive size and growth, the industry faces many challenges when it comes to supply chain consistency. California has 70 […]

Cannabis M&A Spree Continues with Supreme’s Merger with Blissco

August 2nd, 2019 - Ash Stringer

The cannabis industry is quickly moving through a well-known cycle for emerging markets. Like Google in the tech industry, early market entrants that have become successful in a given subset of the fragmented market are starting to look to mergers and acquisitions to expand their geographic and product footprint. The result is often a mature […]

RYAH Signs Partnership Agreement With SOS Cannabis for Reimbursement for Canadian Patients

July 29th, 2019 - Ryan Allway

NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) — RYAH Medtech Inc. (“RYAH” or the “Company”), announced today it has executed a partnership agreement with SOS cannabis (“SOS Cannabis”). The agreement will provide Canadian patients with the ability to obtain free legal representation to seek reimbursement from different government agencies for the medical costs associated with […]

XPhyto Therapeutics: Where Medical Cannabis Meets Modern Science

July 25th, 2019 - Ryan Allway

  It wasn’t long ago that recreational marijuana was legalized in Washington State and Colorado, while speculation about widespread medical marijuana was running rampant across America and then-Canadian Prime Minister candidate Justin Trudeau was making campaign promises for his country to become the second in the world with adult-use marijuana. At that time, so-called “pot […]

First, Last and Always: Cannabis Innovation Never Ends in Israel

July 25th, 2019 - Ash Stringer

When the word “cannabis” is heard, “Israel” probably isn’t one of the first things that jumps to mind. But, for investors it should be. For that matter, so should EuroMed Therapeutics, an upstart heading toward the public domain. Here’s why. Top Notch R&D, Perfect Weather and Locale  First, simply consider the overall startup picture and […]

Synthetic Cannabinoids: The New Age of Medical Marijuana

July 22nd, 2019 - Ryan Allway

Believe it or not, the world’s first blockbuster drug is still one of the most commonly used today. Acetylsalicylic acid, better known as Aspirin®, is a synthetic derivative of the natural substance salicylic acid, an extract from the bark of the white willow tree. Any company would like to invent a drug that enjoys 100+ […]

Strainwise Looks to Build a Cannabis Services Ecosystem

July 22nd, 2019 - Ryan Allway

The global cannabis industry is projected to reach more than $66.3 billion by 2025, according to Grand View Research, which represents a blistering 23.9% compound annual growth rate. There are many different opportunities for investors interested in the space, ranging from cultivators to REITs, but consulting businesses have some unique advantages. For example, they often […]

Supreme Cannabis: At the Epicenter of Premium Products

July 22nd, 2019 - Ash Stringer

The old Aesop axiom advises to be vigilant, for you can be known by the company that you keep. If that’s the case, then Supreme Cannabis (TSX:FIRE) (OTCQX:SPRWF) must feel pretty good, as it has surrounded itself with household names in the burgeoning cannabis industry, albeit in-house, through partnerships or association. In-House Supreme is not […]

SinglePoint’s Direct Solar Shaking Up Industry with Rocket Mortgage Model

July 19th, 2019 - Ash Stringer

Realize it or not, we are in the midst of an energy transformation away from fossil fuels.  Need evidence? Tesla recently shattered its record for electric cars delivered during a quarter. Ford is pumping $500 million into Tesla rival Rivian as the electric car industry heats up. Keeping promises made on the campaign trail, President […]

RYAH Dose Measuring Vaporizer Hits U.S. Dispensary Shelves

July 15th, 2019 - Ryan Allway

NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) — RYAH Medtech Inc. (“RYAH” or the “Company”), announced today that its dose-measuring smart vaporizer and proprietary cartridges have hit medical dispensary shelves in the United States. RYAH selected Sweetspot, a high-end medical dispensary located in Maryland for its flagship launch. “We are excited to see RYAH on […]

Mojave Jane’s California Cannabis Plan

July 15th, 2019 - Ryan Allway

When it comes to building brands in the cannabis space, it pays to be ahead of the curve. Mojave Jane(CSE:JANE) (formerly known as High Hampton Holdings) is a California-centric cannabis company that includes award winning CALIGOLD edibles,  along with manufacturing, distribution, and delivery operations that open the door to produce a host of cannabis products […]

How New Technology from Medical Experts is Simplifying Cannabis Compliance

July 11th, 2019 - Ryan Allway

As we know, a growing number of states have legalized medical and adult-use cannabis, creating a robust industry worth billions of dollars per year. The problem is that cannabis remains illegal on a federal level, which has left states to create a patchwork of ever changing regulations. These regulations can be challenging to any cannabis […]

Cannabis Companies Need to Take It From The Experts

July 10th, 2019 - Ryan Allway

2018 was a momentous year and real turning point for cannabis. Canada became the first G20 country to legalize full adult-use of marijuana. The FDA approved the first cannabis-based drug, Epidiolex for certain rare forms of epilepsy. In a different vertical, Congress passed the Farm Bill, legalizing industrial hemp, a non-intoxicating cousin of marijuana that […]

Israel: A Cannabis Pioneer Then…and Now

July 10th, 2019 - Ash Stringer

When it comes to cannabis, Israel proves that big things can come in small packages. While recreational marijuana remains illegal in Israel, a country about the size of New Hampshire, the government has been proactive in supporting cannabis research for decades while other countries stagnated in the darkness of cannabis prohibition.  In the U.S., cannabis […]

FluroTech: Know Your Product, Improve Your Profits

July 9th, 2019 - Ash Stringer

Regulations surrounding the legal sale of cannabis can be byzantine, to say the least. In North America alone, 33 U.S. states have their own rules about legal use of marijuana, albeit medicinal or recreational, while the plant remains illegal at the federal level. That is unless it contains less than 0.3% tetrahydrocannabinol (THCa), in which […]

Oldest U.S. Cannabis Retailer Goes Public with Big Expansion Plan

July 9th, 2019 - Ryan Allway

  The U.S. cannabis industry is projected to reach $50 billion by 2026, according to Cowen & Co., driven by the legalization of adult-use cannabis across a growing number of jurisdictions. California has already become the dominant force behind the country’s legal cannabis industry following the legalization of adult-use cannabis in 2016. The state generated […]

Sublime Launches California’s First Cannabis-Infused Freezer Pops

July 3rd, 2019 - Ryan Allway

By : Sublime Canna July 2, 2019 Category : CONSUMABLES Freaze ice pops will be available at dispensaries this month OAKLAND, Calif. – July 2, 2019 /Canna Newswire/ – Sublime, an award-winning cannabis manufacturing company located in Oakland, Calif., is launching its latest edible product: Freaze, a cannabis-infused freezer pop. Just in time for the heat […]

The Global Big Data Market Meets RYAH Medtech’s Unique Vaporizer

July 2nd, 2019 - Ash Stringer

  The output of analyzing large blocks of information, or “big data” as it is generally known, to identify trends is one of the most valuable commodities today. One of the beauties of big data is that it can pinpoint trends at all scales, from an individual to an entire country. Another is that it […]

Synthetic Cannabinoids: The Harbinger of Cannabis Pharmaceuticals

June 27th, 2019 - Ryan Allway

Many people hear the phrase ‘synthetic’ cannabinoids and immediately think of deadly designer drugs that have swept the recreational market. But synthetic cannabinoids refer to any cannabinoids that are created through chemical or biological processes other than the cultivation and extraction of cannabis plants. These processes could help make cannabinoids much cheaper and chemically-precise — […]

MJMicro Conference Connecting Cannabis Investors in NYC

June 25th, 2019 - Ryan Allway

There are more than 400 public cannabis companies, and hundreds more are expected to go public over the next 12-18 months, according to Viridian Capital Advisors. With all of this noise in the market, it’s challenging for investors to discern what companies represent the best opportunities, and it’s equally challenging for companies to differentiate themselves. […]

RYAH Medtech announces CE Mark for its RYAH vaporizer to establish critical plant-based dose measuring and data analytics in the European market

June 24th, 2019 - Ryan Allway

NEW YORK, June 20, 2019 (GLOBE NEWSWIRE) — RYAH Medtech Inc. (“RYAH” or the “Company”), announced today that it has received a CE Mark for its dose measuring and data aggregator vaporizer. The certification is a critical part of RYAH’s expansion strategy in the European region for the RYAH dose-measuring plant-based vaporizer, RYAH proprietary dry […]

Taking A Bite Out of The Cannabis Edibles Market

June 24th, 2019 - Ryan Allway

Cannabis edibles and beverages have more than doubled their share of the overall cannabis market since 2011, according to data from ArcView Market Research and BDS Analytics, with revenue projected to grow from $1 billion in 2017 to $4.1 billion by 2022. Consumer appetite for edibles also appears to be rising as people seek out […]

DNA Genetics: A Leader in Cannabis Branding & Licensing

June 24th, 2019 - Ryan Allway

The cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a 34.6% compound annual growth rate. While many companies are focused on cultivation and retail, these business models involve high capital expenditures to produce commoditized products. Investors may be better off looking at companies focused on branding and […]

Lesotho Deputy Prime Minister, Mr. Monyane Moleleki, to Join Halo and Ms. Mojela at European Cannabis Week

June 19th, 2019 - Ryan Allway

TORONTO Ms. Mojela to speak at Global Cannabis Partnership Launch in House of Commons Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Deputy Prime Minister of Lesotho, Mr. Monyane Moleleki will be joining CEO of Halo Labs Kiran Sidhu and Chairman of Bophelo Bioscience […]

Halo Labs Intends to Appoint Ms. Louisa Mojela as Chairman of the Board Upon Closing of Bophelo Bioscience Acquisition

June 19th, 2019 - Ryan Allway

Expected to Become First Ever African Business Woman to Chair a Publicly Traded Cannabis Company Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that upon closing of the previously announced acquisition of Bophelo Bioscience & Wellness (Pty) Ltd. (“Bophelo”) (the “Transaction”), the Company intends to appoint […]

7 Minutes with Matt Willer and a Little Cannabis Alliteration

June 18th, 2019 - Ash Stringer

  Marcus Lemonis, the iconic entrepreneurial Profit, is famously known for building successful businesses under the mantra of “people, process and product.” If there is a company employing the “3 P’s” recipe in the cannabis space, it’s STWC Holdings Inc. (OTCQB: STWC), or Strainwise Consulting as it is often called, a company steeped with experience […]

Halo Labs to Expand Globally and Acquire Bophelo Bioscience

June 17th, 2019 - Ryan Allway

Cannabis Industry in Lesotho, Africa to Become Gateway to EU Cannabis Markets Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has entered into a non-binding letter of intent (LOI) for the proposed acquisition of Bophelo Bioscience & Wellness (Pty) Ltd (“Bophelo”) (the “Transaction”). The […]

FSD Pharma Continues to Add Expert Advisors Amid Buildout of Massive Facility

June 14th, 2019 - Ryan Allway

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) has been focused on building out its board of directors and advisory board since becoming a full Canadian licensed producer earlier this year. After receiving its cultivation license in 2017, the company began work on a massive cultivation facility that could house nearly four million sq. ft. on […]

Rubicon Steps Up to the Cannabis Branding Plate

June 13th, 2019 - Robin Lefferts

  In the rapidly-evolving legal cannabis industry, we’ve gone from complete prohibition to limited medical markets to widespread retail markets in a few short years. In order for licensed producers to compete in the retail marketplace, the need to develop powerful consumer brands has become an incredibly important step for success. Companies that manage to […]

DehydraTECH: The Cynosure of Efficient CBD Delivery

June 13th, 2019 - Ash Stringer

Scientists use words like “bioavailability,” “pharmacokinetics” and “targeted” in describing keys to efficiently treating disease and conditions. To the patient, it is just swallowing a pill, but there is years of research that goes into improving drug delivery with the goal of getting the medicine to the right spot as quickly as possible to maximize […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading